XML 31 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Cash Flows from Operating Activities:    
Net earnings (loss) $ 46.0 $ (43.0)
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:    
Depreciation and amortization 115.9 150.3
Stock-based compensation 15.7 27.0
Amortization of deferred financing costs 3.5 2.6
Pension and post-retirement expenses (7.8) (6.2)
(Gain) on sales of property and dealers 0.0 (2.0)
Deferred taxes (1.2) (16.4)
Restructuring expense 19.8 0.0
Impairment 36.6 15.5
Loss on extinguishment of debt 0.0 13.4
Decrease (increase) in current assets 5.9 (224.9)
(Decrease) increase in current liabilities (159.1) 35.2
(Decrease) in non-current liabilities (5.3) (8.6)
Other, net 0.4 (0.8)
Net Cash Provided by (Used in) Operating Activities 70.4 (57.9)
Cash Flows from Investing Activities:    
Notes receivables issued (4.4) 0.0
Capital expenditures (60.6) (65.8)
Acquisitions, net of cash received 0.0 (1,088.5)
Proceeds from the sale of investments 0.0 7.7
Proceeds from the sale of property and dealers 0.0 2.8
Proceeds from loan on cash surrender value of life insurance 13.5 0.0
Other, net (1.7) (1.2)
Net Cash (Used in) Investing Activities (53.2) (1,145.0)
Cash Flows from Financing Activities:    
Repayments of long-term debt (19.7) (56.6)
Proceeds from issuance of debt, net of discounts 0.0 1,007.0
Payments of deferred financing costs 0.0 (9.3)
Proceeds from credit facility 720.2 815.7
Repayments of credit facility (664.7) (627.7)
Payment of make whole premium on debt 0.0 (13.4)
Dividends paid (42.9) (39.8)
Common stock issued 4.5 6.8
Common stock repurchased and retired (15.9) (16.0)
Other, net (3.6) (5.3)
Net Cash (Used in) Provided by Financing Activities (22.1) 1,061.4
Effect of Exchange Rate Changes on Cash and Cash Equivalents (8.3) (9.0)
Net Decrease in Cash and Cash Equivalents (13.2) (150.5)
Cash and Cash Equivalents, Beginning of Period 230.3 396.4
Cash and Cash Equivalents, End of Period $ 217.1 $ 245.9